AZZ Inc AZZ
5 targets with a reported result
Releases of the last 3 yearsThe numbers AZZ said it expected, in its earnings releases, next to what it then reported for the same period.
Target by target
Each target, with the sentence it came from · release and 10-Q or 10-K
| Target | What the company said | Reported | Result | |
|---|---|---|---|---|
| EBITDA (company-defined) Fiscal 2027 |
Given $360.00M to $400.00M release Apr 22, 2026
Raised $375.00M to $415.00M release Jul 8, 2026
Raised $380.00M to $420.00M release Oct 13, 2026
|
– | No standard number | |
The company's wordsFY2027 Guidance(1) … Adjusted EBITDA $360 - $400 million release Apr 22, 2026 Prior Revised FY2027 Guidance(1) FY2027 Guidance(1) … Adjusted EBITDA $375 - $415 million release Jul 8, 2026 Prior Revised FY2027 Guidance(1) FY2027 Guidance(1) … Adjusted EBITDA $380 - $420 million release Oct 13, 2026 | ||||
| Capital expenditures Fiscal 2027 |
Given $80.00M to $100.00M release Apr 22, 2026
Kept $80.00M to $100.00M release Jul 8, 2026
Kept $80.00M to $100.00M release Oct 13, 2026
|
– | Not reported yet | |
The company's wordsFiscal 2027 capital expenditures are expected to be approximately $80 - $100 million, reflecting an increase in growth capital for hot-dip galvanizing capacity expansions and technology improvements. release Apr 22, 2026 (1) FY2027 Guidance Assumptions: a. … Capital expenditures are expected to be approximately $80 to $100 million, reflecting an increase in growth capital for hot-dip galvanizing capacity expansions and technology improvements for both Metal Coatings and Precoat Metals. release Jul 8, 2026 (1) FY2027 Guidance Assumptions: a. … Capital expenditures are expected to be approximately $80 to $100 million, reflecting an increase in growth capital for hot-dip galvanizing capacity expansions and technology improvements for both Metal Coatings and Precoat Metals. release Oct 13, 2026 | ||||
| Diluted EPS (company-defined) Fiscal 2027 |
Given $6.50 to $7.00 release Apr 22, 2026
Raised $6.75 to $7.15 release Jul 8, 2026
Raised $7.00 to $7.30 release Oct 13, 2026
|
– | No standard number | |
The company's wordsFY2027 Guidance(1) … Adjusted Diluted EPS $6.50 - $7.00 release Apr 22, 2026 Prior Revised FY2027 Guidance(1) FY2027 Guidance(1) … Adjusted Diluted EPS $6.75 - $7.15 release Jul 8, 2026 Prior Revised FY2027 Guidance(1) FY2027 Guidance(1) … Adjusted Diluted EPS $7.00 - $7.30 release Oct 13, 2026 | ||||
| Revenue Fiscal 2027 |
Given $1.73B to $1.77B release Apr 22, 2026
Raised $1.80B to $1.85B release Jul 8, 2026
Raised $1.82B to $1.88B release Oct 13, 2026
|
– | Not reported yet | |
The company's wordsFY2027 Guidance(1) … Sales $1.725 - $1.775 billion release Apr 22, 2026 Prior Revised FY2027 Guidance(1) FY2027 Guidance(1) … Sales $1.80 - $1.85 billion release Jul 8, 2026 Prior Revised FY2027 Guidance(1) FY2027 Guidance(1) … Sales $1.825 - $1.875 billion release Oct 13, 2026 | ||||
| EBITDA (company-defined) Fiscal 2026 (ended Feb 28, 2026) |
Given $360.00M to $400.00M release Apr 21, 2025
Kept $360.00M to $400.00M release Jul 9, 2025
Kept $360.00M to $400.00M release Oct 8, 2025
Lowered $360.00M to $380.00M release Jan 7, 2026
|
– | No standard number | |
The company's wordsFY2026 Guidance(1) … Adjusted EBITDA $360 - $400 million release Apr 21, 2025 FY2026 Guidance(1) … Adjusted EBITDA $360 - $400 million release Jul 9, 2025 FY2026 Guidance(1) … Adjusted EBITDA $360 - $400 million release Oct 8, 2025 FY2026 Guidance(1) … Adjusted EBITDA $360 - $380 million release Jan 7, 2026 | ||||
| Capital expenditures Fiscal 2026 (ended Feb 28, 2026) |
Given $60.00M to $80.00M release Apr 21, 2025
|
$80.78M 10-K filed 2026-04-22 |
Above the range | |
The company's wordsFiscal 2026 capital expenditures are expected to be approximately $60 - $80 million. release Apr 21, 2025 | ||||
| Diluted EPS (company-defined) Fiscal 2026 (ended Feb 28, 2026) |
Given $5.50 to $6.10 release Apr 21, 2025
Raised $5.75 to $6.25 release Jul 9, 2025
Kept $5.75 to $6.25 release Oct 8, 2025
Raised $5.90 to $6.20 release Jan 7, 2026
|
– | No standard number | |
The company's wordsFY2026 Guidance(1) … Adjusted Diluted EPS $5.50 - $6.10 release Apr 21, 2025 FY2026 Guidance(1) … Adjusted Diluted EPS $5.75 - $6.25 release Jul 9, 2025 FY2026 Guidance(1) … Adjusted Diluted EPS $5.75 - $6.25 release Oct 8, 2025 FY2026 Guidance(1) … Adjusted Diluted EPS $5.90 - $6.20 release Jan 7, 2026 | ||||
| Revenue Fiscal 2026 (ended Feb 28, 2026) |
Given $1.62B to $1.73B release Apr 21, 2025
Kept $1.62B to $1.73B release Jul 9, 2025
Kept $1.62B to $1.73B release Oct 8, 2025
Lowered $1.62B to $1.70B release Jan 7, 2026
|
$1.65B 10-K filed 2026-04-22 |
Within the range | |
The company's wordsFY2026 Guidance(1) … Sales $1.625 - $1.725 billion release Apr 21, 2025 FY2026 Guidance(1) … Sales $1.625 - $1.725 billion release Jul 9, 2025 FY2026 Guidance(1) … Sales $1.625 - $1.725 billion release Oct 8, 2025 FY2026 Guidance(1) … Sales $1.625 - $1.7 billion release Jan 7, 2026 | ||||
| EBITDA (company-defined) Fiscal 2025 (ended Feb 28, 2025) |
Given $310.00M to $360.00M release Apr 22, 2024
Kept $310.00M to $360.00M release Jul 10, 2024
Raised $320.00M to $360.00M release Oct 9, 2024
Raised $340.00M to $360.00M release Jan 7, 2025
|
– | No standard number | |
The company's wordsReiterating FY25 Guidance(1) … Adjusted EBITDA $310 - $360 million release Apr 22, 2024 Reiterating FY25 Guidance(1) … Adjusted EBITDA $310 - $360 million release Jul 10, 2024 Revised FY25 Guidance(1) … Adjusted EBITDA $320 - $360 million release Oct 9, 2024 Revised FY25 Guidance(1) … Adjusted EBITDA $340 - $360 million release Jan 7, 2025 | ||||
| Capital expenditures Fiscal 2025 (ended Feb 28, 2025) |
Given $100.00M to $120.00M release Apr 22, 2024
|
$115.88M 10-K filed 2025-04-21 |
Within the range | |
The company's wordsFiscal 2025 capital expenditures are expected to be approximately $100 - $120 million, which includes $50 - $60 million for the greenfield plant construction in Washington, Missouri (completion expected in FY25) and the balance to be allocated to maintenance, productivity enhancements, and environmental, health and safety initiatives. release Apr 22, 2024 | ||||
| Diluted EPS (company-defined) Fiscal 2025 (ended Feb 28, 2025) |
Given $4.50 to $5.00 release Apr 22, 2024
Kept $4.50 to $5.00 release Jul 10, 2024
Raised $4.70 to $5.10 release Oct 9, 2024
Raised $5.00 to $5.30 release Jan 7, 2025
|
– | No standard number | |
The company's wordsReiterating FY25 Guidance(1) … Adjusted Diluted EPS $4.50 - $5.00 release Apr 22, 2024 Reiterating FY25 Guidance(1) … Adjusted Diluted EPS $4.50 - $5.00 release Jul 10, 2024 Revised FY25 Guidance(1) … Adjusted Diluted EPS $4.70 - $5.10 release Oct 9, 2024 Revised FY25 Guidance(1) … Adjusted Diluted EPS $5.00 - $5.30 release Jan 7, 2025 | ||||
| Revenue Fiscal 2025 (ended Feb 28, 2025) |
Given $1.52B to $1.62B release Apr 22, 2024
Kept $1.52B to $1.62B release Jul 10, 2024
Kept $1.52B to $1.62B release Oct 9, 2024
Narrowed $1.55B to $1.60B release Jan 7, 2025
|
$1.58B 10-K filed 2025-04-21 |
Within the range | |
The company's wordsReiterating FY25 Guidance(1) … Sales $1.525 - $1.625 billion release Apr 22, 2024 Reiterating FY25 Guidance(1) … Sales $1.525 - $1.625 billion release Jul 10, 2024 Revised FY25 Guidance(1) … Sales $1.525 - $1.625 billion release Oct 9, 2024 Revised FY25 Guidance(1) … Sales $1.550 - $1.600 billion release Jan 7, 2025 | ||||
| EBITDA (company-defined) Fiscal 2024 (ended Feb 29, 2024) |
Given $315.00M to $335.00M release Jan 9, 2024
|
– | No standard number | |
The company's wordsPrevious Revised FY24 Guidance FY24 Guidance … Adjusted EBITDA $315 - $335 million release Jan 9, 2024 | ||||
| Diluted EPS (company-defined) Fiscal 2024 (ended Feb 29, 2024) |
Given $4.15 to $4.35 release Jan 9, 2024
|
– | No standard number | |
The company's wordsPrevious Revised FY24 Guidance FY24 Guidance … Adjusted Diluted EPS $4.15 - $4.35 release Jan 9, 2024 | ||||
| Revenue Fiscal 2024 (ended Feb 29, 2024) |
Given $1.45B to $1.55B release Jan 9, 2024
|
$1.54B 10-K filed 2024-04-22 |
Within the range | |
The company's wordsPrevious Revised FY24 Guidance FY24 Guidance … Sales $1.45 - $1.55 billion release Jan 9, 2024 | ||||
Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (12 releases since 2024-01-09), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.
Sources
The outlook sentences of each earnings release (8-K item 2.02, exhibit 99), read without AI; results from SEC's XBRL company facts, as first reported.
Also
Earnings releases: each release in full.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/AZZ/export.csv") into a cell.